Fluorine-18 fluoromisonidazole tumour to muscle retention ratio for the detection of hypoxia in nasopharyngeal carcinoma
- 1 October 1996
- journal article
- Published by Springer Nature in European Journal of Nuclear Medicine and Molecular Imaging
- Vol. 23 (10) , 1378-1383
- https://doi.org/10.1007/bf01367595
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Nitroimidazoles and imaging hypoxiaEuropean Journal of Nuclear Medicine and Molecular Imaging, 1995
- Nitroimidazole drugs-action and resistance mechanisms I. Mechanism of actionJournal of Antimicrobial Chemotherapy, 1993
- Imaging of hypoxia in human tumors with [F-18]fluoromisonidazoleInternational Journal of Radiation Oncology*Biology*Physics, 1992
- Measurement of tumor hypoxia by invasive and non-invasive procedures: a review of recent clinical studiesRadiotherapy and Oncology, 1991
- Radiolabeled fluoromisonidazole as an imaging agent for tumor hypoxiaPublished by Elsevier ,1989
- Keynote address: Hypoxic cell radiosensitizers: Where next?International Journal of Radiation Oncology*Biology*Physics, 1989
- Synthesis and biodistribution of 18F-labeled fluoronitroimidazoles: Potential in vivo markers of hypoxic tissueApplied Radiation and Isotopes, 1986
- A Multicomponent X-ray Survival Curve for Mouse Lymphosarcoma Cells irradiated in vivoNature, 1963
- Quantitative measurements of oxygen tension in normal tissues and in the tumours of patients before and after radiotherapyActa Radiologica, 1960
- A Factor of Importance in the Radio Sensitivity of TumoursThe British Journal of Radiology, 1936